Anti-Human CD20 Recombinant Antibody(Ofatumumab)
-
产品编号
YR1129
-
别名
科研级 Ofatumumab ( 奥法木单抗 ), Anti-CD20 Recombinant Antibody, Research Grade Ofatumumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Ofatumumab ( 奥法木单抗 ), Anti-CD20 Recombinant Antibody, Research Grade Ofatumumab |
Catalog Number | YR1129 |
Molecular Name | Ofatumumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 Kappa |
Formulation | PBS, pH7.5 |
Background | Ofatumumab, sold under the brand name Arzerra among others, is a fully human monoclonal antibody to CD20, which appears to inhibit early-stage B lymphocyte activation. It is FDA approved for treating chronic lymphocytic leukemia that is refractory to fludarabine and alemtuzumab (Campath) and for the treatment of multiple sclerosis. |
CAS Number | 679818-59-8 |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Molecular Weight | 149 kDa |
Target | CD20[Homo sapiens] |